Neo Cremar Co. Ltd (311390) fair value: what the stock is really worth
As of Nov 6, 2026: fair value (intrinsic value) of Neo Cremar Co. Ltd stock KRW 3,543, price KRW 1,970, upside +79.9%, quality 57 out of 100. Rating: strongly undervalued. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.
69 individual criteria per stock, every one traceableSee the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year. As of Nov 3, 2026.
How to read this chart
60‑month range 1,970 KRW – 28,919 KRW · fair‑value band 2,480 KRW – 4,606 KRW · the 1,970 KRW price screens below the 3,543 KRW fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). As of Nov 3, 2026.
Follow Neo Cremar Co. in your weekly email
Every Wednesday you see whether Neo Cremar Co. is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
Neo Cremar Co., Ltd. manufactures and sells functional food ingredients and additives in South Korea and internationally. The company offers microbiome, functional carbohydrate, functional protein, solubilizable functional ingredients, organic, and other products.
Show moreShow less
It also provides functional foods, plant-based meat and cultured meat, customized health functional food, and pharmaceuticals business. Neo Cremar Co., Ltd. was founded in 1999 and is headquartered in Seoul, South Korea.
Stock analysis
Neo Cremar Co. Ltd (311390) currently trades at 1,970 KRW, while our model-based Fair Value estimate is 3,543 KRW, implying the stock looks roughly 44% undervalued today.
Show more
Valuation
Bull case: the Growth DCF group reads highest at a median of 17,825 KRW per share, and 23 of the 26 models we run sit above the 1,970 KRW price.
Bear case: the Dividend Discount group reads lowest at 1,262 KRW, and 3 of the 26 models stay below the price. Data coverage for this calculation is low.
Scenario range: 2,480 KRW (bear) to 4,606 KRW (bull), the price of 1,970 KRW sits below it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 57/100 (solid quality), in the Basic Materials sector.
Healthy Growth: Revenue growth appears healthy and is supported by profitability and cash-flow quality.
Neo Cremar Co. Ltd reported revenue of 81.9B KRW in FY2025 versus 29.9B KRW in FY2021, a compound +28.7%/yr. Reported net income was 3.0B KRW in FY2025, compounding +12.9%/yr from FY2021.
Key figures
Market cap 24.9B KRW (≈ $18.4M) Micro · P/E ratio 10.7 · P/S ratio 0.31 · EPS (TTM) 185.34 KRW · Dividend yield 2.5% · Net margin 2.9% · Return on equity 4.9% · Return on assets (EBIT) −0.2% (5-year average).
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 40 out of 100 (medium confidence).
What moves the price
The share trades about 74% below its 52-week high and at its 52-week low, currently below its 200-day average.
For context, the median of 10 Basic Materials peers we cover trades at −43% fair-value upside, at 80%, 311390 screens cheaper than that median.
Fair Value models
Bear2,480 KRWFair Value 3,543 KRWBull4,606 KRW
Price 1,970 KRW · Upside +79.9%
Capped: our models arrive at a very high value here. We deliberately show a more cautious Fair Value.
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above starts from their evidence-weighted blend, not from a single model. In cyclical trough or peak years, after dilution or a stock split it is adjusted afterwards, so it can sit above or below the models. Based on fiscal year 2025 figures (about 10 months old). Earnings retained since then (116.06 KRW per share) are deliberately not added.Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds.Coverage ⓘCoverage = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Best data coverage
Residual Income4,379 KRW4,347 KRW4,524 KRW74
EPV3,573 KRW3,936 KRW4,254 KRW73
FCF DCF14,091 KRW21,461 KRW45,057 KRW72
All 26 models by family
DCF Models
FCF DCF14,091 KRW21,461 KRW45,057 KRW72
Owner Earnings12,462 KRW26,704 KRW56,877 KRW67
5Y Revenue Exit6,692 KRW9,182 KRW14,280 KRW69
5Y EBITDA Exit6,869 KRW9,539 KRW14,718 KRW72
5Y P/E Exit6,747 KRW10,979 KRW16,344 KRW67
10Y Revenue Exit8,811 KRW14,485 KRW17,100 KRW65
10Y EBITDA Exit9,044 KRW14,867 KRW23,882 KRW64
10Y P/E Exit8,955 KRW14,604 KRW22,957 KRW60
Earnings-Based
Graham-Dodd1,614 KRW11,255 KRW15,794 KRW61
Lynch FV5,815 KRW8,307 KRW10,798 KRW59
PEG = 1.05,815 KRW8,307 KRW10,798 KRW55
EPV3,573 KRW3,936 KRW4,254 KRW73
Dividend Discount
Gordon GGM653.63 KRW1,373 KRW2,205 KRW64
DDM Multi-Stage653.63 KRW1,151 KRW1,439 KRW64
Multiples
P/E Multiple2,492 KRW3,323 KRW4,153 KRW63
P/S Multiple3,026 KRW4,035 KRW5,043 KRW57
P/B Multiple4,870 KRW6,493 KRW8,116 KRW55
EV/EBIT3,284 KRW3,904 KRW4,525 KRW65
EV/EBITDA4,075 KRW4,959 KRW5,843 KRW67
EV/Revenue3,681 KRW4,649 KRW5,616 KRW53
Asset-Based
NCAV (Graham)936.94 KRW1,420 KRW1,775 KRW54
Growth DCF
Growth DCF13,343 KRW25,327 KRW45,059 KRW72
Rev-Margin DCF7,159 KRW10,323 KRW17,053 KRW68
Economic Profit
Residual Income4,379 KRW4,347 KRW4,524 KRW74
ROIC Compounder3,573 KRW3,936 KRW4,254 KRW69
Growth Earnings
Growth-Adj P/E6,815 KRW9,735 KRW12,656 KRW65
The fair value above starts from this blend and is adjusted for a cyclical peak year.
Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card.90/100
Revenue growth appears healthy and is supported by profitability and cash-flow quality.
Revenue growth 1 year
+103.3%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+45.3%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+22.4%
Start year 2020 (pandemic)
Revenue growth 9 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+21.3%
’16
’17
’18
’19
’20
’21
’22
’23
’24
’25
What shareholders gained per year (last 5 years), in KRW ⓘWhat the business itself delivers per year: earnings growth per share plus the dividend yield. This is what you get IF the market keeps valuing the stock the same way: it contains no assumption about the market changing its mind. Computed per share, so buybacks count and a merger does not pass as growth. For a company that pays no dividend it is pure earnings growth per share. Period: earnings growth per share as CAGR over the last 5 reported fiscal years (annual statements), plus the current dividend yield. The start value is the median of the three years around the start, so a single crisis year (a pandemic or a write-down) does not distort the rate. Measured in KRW: this currency has depreciated against the euro and dollar over the long run, so part of the nominal rate is currency erosion that never reaches a EUR/USD investor.
+7.1%
Earnings growth per share plus dividend.
Earnings per share, growth per year+4.6%
Dividend (yield on the price)2.5%
Pace: 5 vs 10 years ⓘTwo data points, not a trend model: earnings growth per share over the last 5 fiscal years against the last 10. Labelled "steady" when both rates are within 3 percentage points of each other, otherwise picking up or flattening. Shown only when ten years of history exist.4.6% vs 0.6%, picking up
Profit margin 2020 to 2025 ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.4% → 7%
Price, fair value, quality and upside side by side.
Free, no sign-up
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Specialty Chemicals · 728 stocks
Beats the industry median on 9/13 measures
Overall it ranks above its industry peers.
Valuation
Quality Score57 · Above median
Fair Value upside+79.9% · Top 25%
Profitability
Return on equity (12 months)4.9% · Below median
Return on assets2.8% · Below median
Net margin (12 months)4.9% · Below median
Operating margin (12 months)15.8% · Top 25%
Growth and dividend
Revenue growth (quarter YoY)6.5% · Below median
Dividend yield (12 months)2.5% · Above median
Balance sheet
Debt / equity0.03× · Below median
Valuation Multiplesvs Specialty Chemicals median · lower = cheaper
For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.
Is Neo Cremar Co. Ltd (311390) overvalued or undervalued?
As of Nov 3, 2026, our model estimates a fair value of 3,543 KRW versus a price of 1,970 KRW, about +80% upside (undervalued).
What is the fair value of 311390?
Our model-based fair value for Neo Cremar Co. Ltd is 3,543 KRW (as of Nov 3, 2026), built from audited fundamentals. The current price: 1,970 KRW.
What is the quality score of 311390?
Neo Cremar Co. Ltd has a Quality Score of 57/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Neo Cremar Co. Ltd (311390)?
Our model-based price target is the fair value of 3,543 KRW (as of Nov 3, 2026) from 26 valuation models. Cautious scenario 2,480 KRW, optimistic scenario 4,606 KRW. It is a calculation from audited fundamentals, not an analyst target.
What is the Neo Cremar Co. Ltd stock forecast for 2026?
Our models put fair value at 3,543 KRW, about +80% upside versus a price of 1,970 KRW (undervalued). Cautious scenario 2,480 KRW, optimistic scenario 4,606 KRW. The calculation is refreshed regularly with new filings.
What is the revenue of Neo Cremar Co. Ltd (311390)?
Neo Cremar Co. Ltd reported trailing-twelve-month revenue of about 81.6B KRW (latest available figure, as of Nov 3, 2026).
Does Neo Cremar Co. Ltd pay a dividend?
Neo Cremar Co. Ltd currently shows a dividend yield of 2.54% relative to its recent price (as of Nov 3, 2026).
How much is the dividend of Neo Cremar Co. Ltd (311390) and when is the ex-dividend date?
Neo Cremar Co. Ltd pays a dividend of 50.00 KRW per share a year, a dividend yield of 2.5%. The last ex-dividend date was Mar 30, 2026. The payout ratio is 27.0% of earnings. Free cash flow covers the dividend 23.72 times. Our assessment: Well covered. A low payout and the dividend is fully funded by free cash flow, a comfortable, sustainable dividend.
What is the intrinsic value of Neo Cremar Co. Ltd (311390)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Neo Cremar Co. Ltd it is 3,543 KRW per share (as of Nov 3, 2026), against a price of 1,970 KRW. It is the blended result of 26 valuation models in 8 families (DCF Models, Earnings-Based, Dividend Discount, Multiples, Asset-Based, Growth DCF, Economic Profit, Growth Earnings).
Is Neo Cremar Co. Ltd stock overvalued or undervalued in 2026?
As of Nov 3, 2026, 311390 trades below its calculated fair value: price 1,970 KRW, fair value 3,543 KRW, a gap of about +80% (undervalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of 311390?
No. The price is what the market pays today (1,970 KRW); the fair value is what the company's own numbers justify (3,543 KRW). For Neo Cremar Co. Ltd the two are 1,573 KRW per share apart. That gap is exactly why we show both numbers side by side.
How much is Neo Cremar Co. Ltd worth?
The market values Neo Cremar Co. Ltd at about 24.9B KRW (market capitalisation, as of Nov 3, 2026). Per share that is 1,970 KRW; our models calculate a fair value of 3,543 KRW per share.
What do the bullish and bearish scenarios say about 311390?
Our models span a range for Neo Cremar Co. Ltd: cautious scenario 2,480 KRW, base 3,543 KRW, optimistic 4,606 KRW per share (as of Nov 3, 2026, price 1,970 KRW). The range comes from different growth and margin assumptions, not from analyst opinions.
What is the P/E ratio of 311390?
Neo Cremar Co. Ltd trades at a price-to-earnings ratio of 10.7 (as of Nov 3, 2026). A P/E on its own says little: it compares the price with ONE year of profit, while our fair value of 3,543 KRW is built from several models across several years. Median P/E at fiscal year-end, 5 fiscal years (2019 to 2025), reported earnings: 65.8. Other multiples: P/B 0.3, P/S 0.5.
How solid is the balance sheet of Neo Cremar Co. Ltd (311390)?
Balance-sheet figures for Neo Cremar Co. Ltd (as of Nov 3, 2026): return on equity 4.9%, debt of 0.03 per unit of equity. They feed the Quality Score of 57/100, which measures business quality independently of the share price.
How far is 311390 from its 52-week high?
Neo Cremar Co. Ltd trades at 1,970 KRW, about 74% below its 52-week high of 7,465 KRW and at the low of 1,970 KRW (as of Nov 6, 2026). Distance from the high says nothing about value: that is what the fair value of 3,543 KRW is for.
Which stocks are comparable to Neo Cremar Co. Ltd?
From the same area (Basic Materials) we also value Linde plc, Ecolab Inc, The Sherwin-Williams Company, Nan Ya Plastics Corporation, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Neo Cremar Co. Ltd stock attractive at the current price?
The data as of Nov 3, 2026: price 1,970 KRW, calculated fair value 3,543 KRW (+80%), Quality Score 57/100, from 26 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of 311390 calculated?
We run Neo Cremar Co. Ltd through 26 models from 8 families: DCF Models, Earnings-Based, Dividend Discount, Multiples, Asset-Based, Growth DCF, Economic Profit, Growth Earnings. Every model gets the same audited fundamentals; the fair value of 3,543 KRW builds on their evidence-weighted average, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 13.3% above its aggregate fair value. Neo Cremar Co. Ltd currently trades 44% below its own fair value, and the market average says nothing about that. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Neo Cremar Co. Ltd (311390)?
The closing price on Nov 6, 2026 was 1,970 KRW. Our model-based fair value is 3,543 KRW, about +80% upside (undervalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Neo Cremar Co. Ltd right now?
The price is below even our cautious bear case (2,480 KRW). The market is more pessimistic than our downside scenario. The large gap to fair value rests on thin data (low evidence): fewer applicable models and a shorter history. Read it with extra caution. Solid quality (57/100) at a price below fair value, the discount is the argument here, not the business quality. A fairly wide model range (2,480 KRW to 4,606 KRW) leaves room in how you read the outcome.
Key figures of Neo Cremar Co. Ltd
How large is the market capitalisation of Neo Cremar Co. Ltd (311390)?
The market capitalisation of Neo Cremar Co. Ltd is 24.9B KRW (≈ $18.4M). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Neo Cremar Co. Ltd (311390)?
The price-to-sales ratio of Neo Cremar Co. Ltd is 0.31 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Neo Cremar Co. Ltd (311390)?
Earnings per share at Neo Cremar Co. Ltd are 185.34 KRW (price ÷ EPS = P/E 10.7). Earnings per share over the last twelve months: total profit spread across every single share.
What is the dividend yield of Neo Cremar Co. Ltd (311390)?
The dividend yield of Neo Cremar Co. Ltd is 2.5% (payout 27.0%). Yearly dividend relative to the share price. 3% pays 3 per 100 invested. Below: how much of profit is used for it.
What is the net margin of Neo Cremar Co. Ltd (311390)?
The net margin of Neo Cremar Co. Ltd is 2.9% (last twelve months). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Neo Cremar Co. Ltd (311390)?
The return on equity (ROE) of Neo Cremar Co. Ltd is 4.9% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Neo Cremar Co. Ltd (311390)?
On an EBIT basis the return on assets of Neo Cremar Co. Ltd is −0.2% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Neo Cremar Co. Ltd (311390)?
The operating margin of Neo Cremar Co. Ltd is 15.8% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Neo Cremar Co. Ltd (311390)?
Revenue at Neo Cremar Co. Ltd is growing +6.5% versus a year earlier (3y avg +45.3%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at Neo Cremar Co. Ltd (311390)?
Earnings per share at Neo Cremar Co. Ltd are growing +30.1% versus a year earlier. How much earnings per share grew versus a year earlier.
How much free cash flow does Neo Cremar Co. Ltd (311390) generate?
The free cash flow of Neo Cremar Co. Ltd is 14.9B KRW (fiscal year 2025). The cash truly left after running and investing in the business, this is what pays dividends and buybacks.
Free · no account needed
Watch Neo Cremar Co. Ltd in the live analysis
One click puts Neo Cremar Co. Ltd on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.
Thin data
Nov 3, 2026